GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: a prospective trial

被引:0
|
作者
Meduri, B. [1 ]
Aluisio, G. [1 ]
D'Angelo, E. [1 ]
Vernaleone, M. [1 ]
Tata, C. [1 ]
Gelsomino, F. [2 ]
Spallanzani, A. [2 ]
Ballarin, R. [3 ]
Luppi, G. [2 ]
Di Benedetto, F. [4 ]
Lohr, F. [5 ]
机构
[1] Azienda Osped Univ Modena, Dept Oncol, Radiat Oncol Unit, Modena, Italy
[2] Azienda Osped Univ Modena, Dept Oncol, Med Oncol Unit, Modena, Italy
[3] Azienda Osped Univ Modena, Dept Surg, Hepatopancreatobiliary & Liver Transplant Unit, Modena, Italy
[4] Univ Modena & Reggio Emilia, Dept Surg, Hepatopancreatobiliary & Liver Transplant Unit, Modena, Italy
[5] Univ Modena & Reggio Emilia, Dept Oncol, Radiat Oncol Unit, Modena, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-1047
引用
收藏
页码:S557 / S557
页数:1
相关论文
共 50 条
  • [21] NEOADJUVANT GEMOX FOLLOWED BY GEM-BASED CHEMORADIATION FOR LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER
    Vaccaro, V.
    Sperduti, I.
    Bria, E.
    Saracino, B.
    Pino, M. S.
    Grazi, G.
    Gelibter, A.
    Vallati, G.
    Cognetti, F.
    Milella, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 237 - 238
  • [22] SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients
    Comito, T.
    Franzese, C.
    Clerici, E.
    Di Brina, L.
    Tozzi, A.
    Iftode, C.
    Franceschini, D.
    Carta, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S771 - S772
  • [23] Stereotactic body radiation therapy (SBRT) for locally advanced pancreatic cancer (LAPC)
    Vera Merino, M.
    Nino de Guzman, C.
    Angel Schutte, D.
    Venencia, D.
    Suarez Villasmil, L.
    Zunino, S.
    ANNALS OF ONCOLOGY, 2018, 29 : 11 - 11
  • [24] High- versus low-dose rate brachytherapy for locally advanced cervical cancer
    Patankar, S. S.
    Tergas, Al.
    Burke, W. M.
    Hou, J. Y.
    Ananth, C.
    Huang, Y.
    Neugut, A.
    Hershman, D.
    Wright, J. D.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 29 - 29
  • [25] R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy
    Kamachi, Hirofumi
    Tsuruga, Yousuke
    Orimo, Tatsuya
    Wakayama, Kenji
    Shimada, Shingo
    Nagatsu, Akihisa
    Yokoo, Hideki
    Kamiyama, Toshiya
    Katoh, Norio
    Taketomi, Akinobu
    IN VIVO, 2018, 32 (05): : 1183 - 1191
  • [26] Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design
    Cattaneo, G.
    Passoni, P.
    Esposito, D.
    Bettinardi, B.
    Reni, M.
    Broggi, S.
    Tamborra, P.
    Di Muzio, N.
    Fazio, F.
    Calandrino, R.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S498 - S498
  • [27] Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer
    Ina, Shinomi
    Tani, Masaji
    Kawai, Manabu
    Hirono, Seiko
    Miyazawa, Motoki
    Nishioka, Ryohei
    Fujita, Yoichi
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2373 - 2377
  • [28] Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial
    Sakamoto, H
    Kitano, M
    Suetomi, Y
    Takeyama, Y
    Ohyanagi, H
    Nakai, T
    Yasuda, C
    Kudo, M
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (01) : 70 - 76
  • [29] Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial
    Hiroki Sakamoto
    Masayuki Kitano
    Yoichirou Suetomi
    Yoshifumi Takeyama
    Harumasa Ohyanagi
    Takuya Nakai
    Chikao Yasuda
    Masatoshi Kudo
    Journal of Gastroenterology, 2006, 41 : 70 - 76
  • [30] Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
    Passardi, Alessandro
    Scarpi, Emanuela
    Neri, Elisa
    Parisi, Elisabetta
    Ghigi, Giulia
    Ercolani, Giorgio
    Gardini, Andrea
    La Barba, Giuliano
    Pagan, Flavia
    Casadei-Gardini, Andrea
    Valgiusti, Martina
    Ferroni, Fabio
    Frassineti, Giovanni Luca
    Romeo, Antonino
    CANCERS, 2019, 11 (05)